Beyond the Hype: Decoding Gen Z's Blind Box Obsession

04-02

VOOPOO Unveiled ARGUS G3—A Revolutionary POD with Smoother Vaping and Extended Power

03-25

How Short Video Platform "Breaks Through the Circle"? Icloud Box Offers a Scientific Solution!

03-25

2024 China-ASEAN College Students' AI Application Innovation Invitation Competition Came to a Successful Concluded

KUALA LUMPUR,Malaysia,March 19,2025-- On March 11,the 2024China-ASEAN College Students\' AI Application Innovation Invitation Competition successfully concluded. The competition attracted 168 teams fr

03-20

Raythink Introduces Cutting-Edge Fire Prevention Solutions at SECON 2025

YANTAI,China,March 19,2025-- Raythink Technology Co.,Ltd. ("Raythink"),an innovator in the thermal imaging industry,is making a high-profile appearance at Secon 2025in Korea. Raythink is sho

03-20

12 Types of Security Cameras and How to Choose the Right One

ZHUHAI,China,March 19,2025-- As businesses seek smarter security solutions,advanced camera technology is playing a key role in improving surveillance and asset protection.Supertek,a leading camera mod

03-20

Altair One® Cloud Innovation Gateway Achieves Seamless Integration with NVIDIA Omniverse Blueprint for Real-Time Digital Twins

Altair,supported by NVIDIA technology,will further drive innovation in simulation-driven design,AI-powered engineering,and computational intelligence

03-20

Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific

FREMONT,Calif.,March 19,2025-- Alamar Biosciences,a company powering precision proteomics to enable the earliest detection of disease,is pleased to announce the signing of five new distribution partne

03-20

Ping An Reports Stable Growth in Operating Profit Attributable to Shareholders of the Parent Company in 2024, Net Profit Attributable to Shareholders of the Parent Company Surges 47.8% YoY

Cash Dividend Increases for 13th Consecutive Year HONG KONG and SHANGHAI,March 19,2025-- Ping An Insurance (Group) Company of China,Ltd. (hereafter "Ping An" or the "Group",HKEX: 2

03-20

Henlius Receives Orphan Drug Designation for Innovative Anti-HER2 mAb HLX22 in the U.S. for Gastric Cancer

SHANGHAI,March 19,2025-- Shanghai Henlius Biotech,Inc. (2696.HK) announced that the U.S.Food and Drug Administration(FDA) has granted Orphan Drug Designation (ODD) for HLX22,the company\'s innovativea

03-20